These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35064738)

  • 1. The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients.
    Pagliari MT; Baronciani L; Cordiglieri C; Colpani P; Cozzi G; Siboni SM; Peyvandi F
    Haemophilia; 2022 Mar; 28(2):292-300. PubMed ID: 35064738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.
    Baronciani L; Federici AB; Cozzi G; Canciani MT; Mannucci PM
    J Thromb Haemost; 2007 Feb; 5(2):282-8. PubMed ID: 17155947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization.
    Baronciani L; Federici AB; Punzo M; Solimando M; Cozzi G; La Marca S; Rubini V; Canciani MT; Mannucci PM
    J Thromb Haemost; 2009 Jul; 7(7):1114-22. PubMed ID: 19422453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.
    Wang JW; Groeneveld DJ; Cosemans G; Dirven RJ; Valentijn KM; Voorberg J; Reitsma PH; Eikenboom J
    Haematologica; 2012 Jun; 97(6):859-66. PubMed ID: 22207689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients.
    Pagliari MT; Baronciani L; Stufano F; Garcia-Oya I; Cozzi G; Franchi F; Peyvandi F
    Haemophilia; 2016 Nov; 22(6):e502-e511. PubMed ID: 27785872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage and secretion of naturally occurring von Willebrand factor A domain variants.
    Groeneveld DJ; Wang JW; Mourik MJ; Dirven RJ; Valentijn KM; Voorberg J; Reitsma PH; Eikenboom J
    Br J Haematol; 2014 Nov; 167(4):529-40. PubMed ID: 25103891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention.
    Yadegari H; Biswas A; Ahmed S; Naz A; Oldenburg J
    Hum Mutat; 2021 Jun; 42(6):731-744. PubMed ID: 33942438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.
    Rayes J; Hommais A; Legendre P; Tout H; Veyradier A; Obert B; Ribba AS; Girma JP
    J Thromb Haemost; 2007 Feb; 5(2):321-8. PubMed ID: 17087728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.
    Daidone V; Barbon G; Pontara E; Cattini GM; Gallinaro L; Zampese E; Pizzo P; Casonato A
    Thromb Haemost; 2014 Dec; 112(6):1159-66. PubMed ID: 25230768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
    Bowman M; Casey L; Selvam SN; Lima PDA; Rawley O; Hinds M; Tuttle A; Grabell J; Iorio A; Walker I; Lillicrap D; James P
    J Thromb Haemost; 2022 Jul; 20(7):1599-1609. PubMed ID: 35466528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.
    Castaman G; Giacomelli SH; Jacobi P; Obser T; Budde U; Rodeghiero F; Haberichter SL; Schneppenheim R
    J Thromb Haemost; 2010 Sep; 8(9):2011-6. PubMed ID: 20586924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.
    Wang JW; Valentijn KM; de Boer HC; Dirven RJ; van Zonneveld AJ; Koster AJ; Voorberg J; Reitsma PH; Eikenboom J
    J Biol Chem; 2011 Jul; 286(27):24180-8. PubMed ID: 21596755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
    Pagliari MT; Rosendaal FR; Ahmadinejad M; Badiee Z; Baghaipour MR; Baronciani L; Benítez Hidalgo O; Bodó I; Budde U; Castaman G; Eshghi P; Goudemand J; Karimi M; Keikhaei B; Lassila R; Leebeek FWG; Lopez Fernandez MF; Mannucci PM; Marino R; Oldenburg J; Peake I; Santoro C; Schneppenheim R; Tiede A; Toogeh G; Tosetto A; Trossaert M; Yadegari H; Zetterberg EMK; Peyvandi F; Federici AB; Eikenboom J
    J Thromb Haemost; 2022 May; 20(5):1106-1114. PubMed ID: 35092343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
    Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
    Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor.
    Christophe O; Ribba AS; Baruch D; Obert B; Rouault C; Niinomi K; Piétu G; Meyer D; Girma JP
    Blood; 1994 Jun; 83(12):3553-61. PubMed ID: 8204881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
    Hommais A; Stépanian A; Fressinaud E; Mazurier C; Pouymayou K; Meyer D; Girma JP; Ribba AS
    Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.
    Sanders YV; Groeneveld D; Meijer K; Fijnvandraat K; Cnossen MH; van der Bom JG; Coppens M; de Meris J; Laros-van Gorkom BA; Mauser-Bunschoten EP; Leebeek FW; Eikenboom J;
    Blood; 2015 May; 125(19):3006-13. PubMed ID: 25673639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.